<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02416791</url>
  </required_header>
  <id_info>
    <org_study_id>513.207</org_study_id>
    <nct_id>NCT02416791</nct_id>
  </id_info>
  <brief_title>Robotic Therapy and Transcranial Direct Current Stimulation in Patients With Stroke</brief_title>
  <acronym>ROTS</acronym>
  <official_title>Robotic Therapy and Transcranial Direct Current Stimulation in Patients With Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke is the second cause of death worldwide and represented the first cause of death in&#xD;
      Brazil between 2006 and 2010. Most patients survive, and there is a need to develop&#xD;
      cost-effective rehabilitation strategies to decrease the burden of disability from stroke.&#xD;
      This study addresses this important issue, by combining two different interventions in the&#xD;
      early phase post-stroke: robotic therapy associated or not with transcranial direct current&#xD;
      stimulation (tDCS), as adjuvant interventions to conventional physical therapy, for motor&#xD;
      upper limb rehabilitation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our main goal is to confirm the safety of robotic therapy associated with active tDCS and&#xD;
      conventional therapy, compared to robotic therapy associated with sham tDCS and to&#xD;
      conventional therapy, and to conventional therapy alone, for upper limb rehabilitation in an&#xD;
      early phase (3-9 weeks) after stroke. Patients will be randomized to receive one of these&#xD;
      three treatments, 3 times per week, for 6 weeks.&#xD;
&#xD;
      Data about eventual adverse effect will be collected in each session of treatment. The&#xD;
      working hypothesis is that robotic therapy associated with active tDCS and conventional&#xD;
      therapy will be as safe as robotic therapy associated with conventional therapy, and as&#xD;
      conventional therapy alone.&#xD;
&#xD;
      We will aso preliminarily evaluate the efficacy of robotic therapy associated with active&#xD;
      tDCS and conventional therapy, compared to robotic therapy associated with sham tDCS and to&#xD;
      conventional therapy alone, in improvement of upper limb motor impairment.&#xD;
&#xD;
      Our secondary goals are: 1) To evaluate safety and upper limb motor impairments in patients&#xD;
      submitted to each of the three interventions, 6 months after end of treatment; 2) To compare&#xD;
      effects of the abovementioned interventions on disability, spasticity and quality of life, in&#xD;
      patients at an early stage after stroke, immediately after treatment and 6 months later.&#xD;
&#xD;
      The working hypothesis is that the association of robotic therapy, tDCS and conventional&#xD;
      therapy will lead to better outcomes than robotic therapy and conventional therapy, or&#xD;
      conventional therapy alone.&#xD;
&#xD;
      Patients will be assessed before the first session and after the last session of treatment,&#xD;
      as well as 6 months after the last session of treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Because of low recruitment rates&#xD;
  </why_stopped>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Upper Extremity Fugl Meyer Assessment</measure>
    <time_frame>6 weeks from baseline</time_frame>
    <description>Change in Motor function subscale was assessed. Scores range from 0 to 66. Lower scores indicate greater severity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Sessions With Adverse Events</measure>
    <time_frame>Post treatment (6 weeks from baseline).</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Modified Rankin Scale</measure>
    <time_frame>6 weeks from baseline</time_frame>
    <description>Scores range from 0 to 6. Higher scores indicate greater severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in National Institutes of Health Stroke Scale</measure>
    <time_frame>6 weeks from baseline</time_frame>
    <description>Scores range from 0 to 42. Higher scores indicate greater severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Stroke Impact Scale</measure>
    <time_frame>6 weeks from baseline</time_frame>
    <description>Scores in each domain of the Stroke Impact Scale range from 0 to 100, with higher scores indicating a better quality of life. The change was calculated as the value at the later time point minus the value at the earlier time point; so that, positive numbers represent increases and negative numbers represent decreases.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Presented Score on Modified Ashworth Scale &gt;2</measure>
    <time_frame>6 weeks</time_frame>
    <description>Scores range from 0 to 4, with 5 choices. A score of 1 indicates no resistance, and 4 indicates rigidity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Motor Activity Log</measure>
    <time_frame>6 weeks from baseline</time_frame>
    <description>Each domain contains taks scored on 0 to 5 ordinal scale. Lower scores indicate greater severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper Extremity Fugl Meyer Assessment</measure>
    <time_frame>6 months follow-up</time_frame>
    <description>Motor function subscale was assessed. Scores range from 0 to 66. Lower scores indicate greater severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Adverse Events</measure>
    <time_frame>6 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fatigue Severity Scale</measure>
    <time_frame>6 weeks from baseline</time_frame>
    <description>Fatigue Severity Scale is a 9 -item questionnaire. Each item scores on a 7-point scale.&#xD;
The total score range from 9 to 63 points. Higher scores indicate greater fatigue.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pittsburgh Sleep Quality Index</measure>
    <time_frame>6 weeks from baseline</time_frame>
    <description>The global Pittsburgh Sleep Quality Index score is calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21. Lower scores denote a healthier sleep quality.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Active tDCS + robotic therapy + physical therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS + robotic therapy + physical therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS + physical therapy + occupational therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robotic Therapy</intervention_name>
    <description>Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.</description>
    <arm_group_label>Active tDCS + robotic therapy + physical therapy</arm_group_label>
    <arm_group_label>sham tDCS + robotic therapy + physical therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active tDCS</intervention_name>
    <description>Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).</description>
    <arm_group_label>Active tDCS + robotic therapy + physical therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham tDCS</intervention_name>
    <description>In sham tDCS, no current will be delivered through the tDCS device.</description>
    <arm_group_label>sham tDCS + physical therapy + occupational therapy</arm_group_label>
    <arm_group_label>sham tDCS + robotic therapy + physical therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Therapy</intervention_name>
    <description>Physical therapy will be administered for 40 minutes.</description>
    <arm_group_label>Active tDCS + robotic therapy + physical therapy</arm_group_label>
    <arm_group_label>sham tDCS + physical therapy + occupational therapy</arm_group_label>
    <arm_group_label>sham tDCS + robotic therapy + physical therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Occupational Therapy</intervention_name>
    <description>Occupational therapy will be administered for 40 minutes.</description>
    <arm_group_label>sham tDCS + physical therapy + occupational therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ischemic or hemorrhagic stroke onset 3 - 9 weeks before the recruiting, confirmed by&#xD;
             computed tomography or magnetic resonance imaging.&#xD;
&#xD;
          -  Moderate to severe motor impairment of an upper limb, defined as a score between 7 -&#xD;
             42 on the Upper Limb Subscale of Fugl Meyer Assessment of Sensorimotor Recovery after&#xD;
             stroke.&#xD;
&#xD;
          -  Ability to provide written informed consent (patient ou legal representative)&#xD;
&#xD;
          -  Ability to comply with the schedule of interventions and evaluations in the protocol.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe spasticity at the paretic elbow, wrist or fingers, defined as a score of &gt; 3 on&#xD;
             the Modified Ashworth Spasticity Scale.&#xD;
&#xD;
          -  Upper limb plegia&#xD;
&#xD;
          -  Uncontrolled medical problems such as end-stage cancer or renal disease&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Seizures, except for a single seizure during the first week post stroke&#xD;
&#xD;
          -  Pacemakers&#xD;
&#xD;
          -  Other neurological disorders such as Parkinson's disease&#xD;
&#xD;
          -  Psychiatric illness including severe depression&#xD;
&#xD;
          -  Aphasia ou severe cognitive deficits that compromise comprehension of the experimental&#xD;
             protocol or ability to provide consent.&#xD;
&#xD;
          -  Hemineglect&#xD;
&#xD;
          -  Drugs that interfere on cortical excitability, except for antidepressants&#xD;
&#xD;
          -  Cerebellar lesions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adriana B Conforto, MD Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clínicas</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>05403900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <study_first_submitted>February 20, 2015</study_first_submitted>
  <study_first_submitted_qc>April 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2015</study_first_posted>
  <results_first_submitted>June 1, 2020</results_first_submitted>
  <results_first_submitted_qc>October 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 20, 2020</results_first_posted>
  <last_update_submitted>October 15, 2020</last_update_submitted>
  <last_update_submitted_qc>October 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>robotic therapy</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
          <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
        </group>
        <group group_id="P2">
          <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
          <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
        </group>
        <group group_id="P3">
          <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
          <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>6 Weeks</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>6 Months</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
          <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
        </group>
        <group group_id="B2">
          <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
          <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
        </group>
        <group group_id="B3">
          <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
          <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="3"/>
            <count group_id="B4" value="9"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.3" spread="15.2"/>
                    <measurement group_id="B2" value="53.33" spread="4.02"/>
                    <measurement group_id="B3" value="54.0" spread="8.52"/>
                    <measurement group_id="B4" value="54.22" spread="10.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ethnicity</title>
              <category_list>
                <category>
                  <title>Back</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time since stroke</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.3" spread="11.1"/>
                    <measurement group_id="B2" value="40.0" spread="16.75"/>
                    <measurement group_id="B3" value="36.66" spread="11.11"/>
                    <measurement group_id="B4" value="41.56" spread="15.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Manual dominance</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Right</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Left</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hemisphere lesioned</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Right hemisphere</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Left hemisphere</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Upper Extremity Fugl Meyer Assessment</title>
          <description>Motor function subscale was assessed. Scores range from 0 - 66. Lower scores indicate greater severity.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.3" spread="9.8"/>
                    <measurement group_id="B2" value="17.7" spread="4.2"/>
                    <measurement group_id="B3" value="21.7" spread="7.8"/>
                    <measurement group_id="B4" value="18.89" spread="6.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mini Mental State Exam</title>
          <description>Scores range from 0 to 30. Lower scores indicate greater severity.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20" lower_limit="14" upper_limit="28"/>
                    <measurement group_id="B2" value="27" lower_limit="23" upper_limit="28"/>
                    <measurement group_id="B3" value="25" lower_limit="22" upper_limit="29"/>
                    <measurement group_id="B4" value="25" lower_limit="14" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>National Institutes of Health Stroke Scale</title>
          <description>Scores range from 0 -42. Higher scores indicate greater severity.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6" lower_limit="4" upper_limit="11"/>
                    <measurement group_id="B2" value="6" lower_limit="2" upper_limit="8"/>
                    <measurement group_id="B3" value="3" lower_limit="2" upper_limit="4"/>
                    <measurement group_id="B4" value="4" lower_limit="2" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified Rankin Scale</title>
          <description>Scores range from 0 to 6. Higher scores indicate greater severity.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="B2" value="3" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="B3" value="3" lower_limit="3" upper_limit="3"/>
                    <measurement group_id="B4" value="3" lower_limit="3" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hospital Anxiety and Depression Scale</title>
          <description>Both subscales (Anxiety and Depression subscales) were assessed. Scores range from 0 to 42. Higher scores indicate greater severity.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8" lower_limit="7" upper_limit="13"/>
                    <measurement group_id="B2" value="6" lower_limit="2" upper_limit="9"/>
                    <measurement group_id="B3" value="8" lower_limit="6" upper_limit="15"/>
                    <measurement group_id="B4" value="8" lower_limit="2" upper_limit="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Upper Extremity Fugl Meyer Assessment</title>
        <description>Change in Motor function subscale was assessed. Scores range from 0 to 66. Lower scores indicate greater severity.</description>
        <time_frame>6 weeks from baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Upper Extremity Fugl Meyer Assessment</title>
          <description>Change in Motor function subscale was assessed. Scores range from 0 to 66. Lower scores indicate greater severity.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.6" spread="7.3"/>
                    <measurement group_id="O2" value="12.3" spread="11.4"/>
                    <measurement group_id="O3" value="22.3" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Sessions With Adverse Events</title>
        <time_frame>Post treatment (6 weeks from baseline).</time_frame>
        <population>RT: robotic therapy; OT: occupational therapy; PT: physical therapy Sham tDCS +RT + PT: 3 participants;each participant was supposed to participate in 18 sessions = 54 sessions in total; there was seven absences and the total number of sessions was 47 for the three patients.</population>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Sessions With Adverse Events</title>
          <population>RT: robotic therapy; OT: occupational therapy; PT: physical therapy Sham tDCS +RT + PT: 3 participants;each participant was supposed to participate in 18 sessions = 54 sessions in total; there was seven absences and the total number of sessions was 47 for the three patients.</population>
          <units>percentage of sessions</units>
          <param>Number</param>
          <units_analyzed>Number of sessions</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Number of sessions</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="47"/>
                <count group_id="O3" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain reported during tDCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue reported during tDCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tingling reported during tDCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="27.7"/>
                    <measurement group_id="O3" value="37.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Burning reported during tDCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2.1"/>
                    <measurement group_id="O3" value="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hot reported during tDCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pinching reported during tDCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4"/>
                    <measurement group_id="O2" value="31.9"/>
                    <measurement group_id="O3" value="30.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metallic taste reported during tDCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Itching reported during tDCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6"/>
                    <measurement group_id="O2" value="2.1"/>
                    <measurement group_id="O3" value="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain reported during RT or OT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7"/>
                    <measurement group_id="O2" value="24.3"/>
                    <measurement group_id="O3" value="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue reported during RT or OT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.9"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dizziness reported during RT or OT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Syncope reported during RT or OT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seizure reported during RT or OT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sleepiness reported during RT or OT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4"/>
                    <measurement group_id="O2" value="6.4"/>
                    <measurement group_id="O3" value="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dysesthesia reported during RT or OT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain reported during PT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3"/>
                    <measurement group_id="O2" value="23.4"/>
                    <measurement group_id="O3" value="24.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue reported during PT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dizziness reported during PT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Syncope reported during FT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Seizure reported during PT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sleepiness reported during PT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="6.4"/>
                    <measurement group_id="O3" value="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dysesthesia reported during PT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Modified Rankin Scale</title>
        <description>Scores range from 0 to 6. Higher scores indicate greater severity.</description>
        <time_frame>6 weeks from baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Modified Rankin Scale</title>
          <description>Scores range from 0 to 6. Higher scores indicate greater severity.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="-1"/>
                    <measurement group_id="O3" value="-1" lower_limit="-1" upper_limit="-1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in National Institutes of Health Stroke Scale</title>
        <description>Scores range from 0 to 42. Higher scores indicate greater severity.</description>
        <time_frame>6 weeks from baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in National Institutes of Health Stroke Scale</title>
          <description>Scores range from 0 to 42. Higher scores indicate greater severity.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3" lower_limit="-5" upper_limit="0"/>
                    <measurement group_id="O2" value="-1" lower_limit="-2" upper_limit="-1"/>
                    <measurement group_id="O3" value="-2" lower_limit="-3" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Stroke Impact Scale</title>
        <description>Scores in each domain of the Stroke Impact Scale range from 0 to 100, with higher scores indicating a better quality of life. The change was calculated as the value at the later time point minus the value at the earlier time point; so that, positive numbers represent increases and negative numbers represent decreases.</description>
        <time_frame>6 weeks from baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Stroke Impact Scale</title>
          <description>Scores in each domain of the Stroke Impact Scale range from 0 to 100, with higher scores indicating a better quality of life. The change was calculated as the value at the later time point minus the value at the earlier time point; so that, positive numbers represent increases and negative numbers represent decreases.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Strength</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.6" spread="7.7"/>
                    <measurement group_id="O2" value="16.7" spread="7.8"/>
                    <measurement group_id="O3" value="10.4" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Memory</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.9" spread="4.4"/>
                    <measurement group_id="O2" value="14.3" spread="10.4"/>
                    <measurement group_id="O3" value="-1.2" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emotions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" spread="13.6"/>
                    <measurement group_id="O2" value="5.5" spread="3.1"/>
                    <measurement group_id="O3" value="3.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Comunication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="6.7"/>
                    <measurement group_id="O2" value="6.0" spread="1.7"/>
                    <measurement group_id="O3" value="3.6" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Activities of daily living</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.1" spread="22.4"/>
                    <measurement group_id="O2" value="25.8" spread="10.0"/>
                    <measurement group_id="O3" value="20.0" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mobility</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.1" spread="30.4"/>
                    <measurement group_id="O2" value="15.8" spread="1.0"/>
                    <measurement group_id="O3" value="20.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HandFunction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" spread="12.2"/>
                    <measurement group_id="O2" value="36.7" spread="0.3"/>
                    <measurement group_id="O3" value="46.6" spread="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Participation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="34.7"/>
                    <measurement group_id="O2" value="15.6" spread="6.6"/>
                    <measurement group_id="O3" value="-6.2" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Presented Score on Modified Ashworth Scale &gt;2</title>
        <description>Scores range from 0 to 4, with 5 choices. A score of 1 indicates no resistance, and 4 indicates rigidity.</description>
        <time_frame>6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Presented Score on Modified Ashworth Scale &gt;2</title>
          <description>Scores range from 0 to 4, with 5 choices. A score of 1 indicates no resistance, and 4 indicates rigidity.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Motor Activity Log</title>
        <description>Each domain contains taks scored on 0 to 5 ordinal scale. Lower scores indicate greater severity.</description>
        <time_frame>6 weeks from baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Motor Activity Log</title>
          <description>Each domain contains taks scored on 0 to 5 ordinal scale. Lower scores indicate greater severity.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Amount of Movement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.4"/>
                    <measurement group_id="O2" value="0.4" spread="0.4"/>
                    <measurement group_id="O3" value="0.6" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quality of Movement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.4"/>
                    <measurement group_id="O2" value="0.5" spread="0.6"/>
                    <measurement group_id="O3" value="0.8" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Upper Extremity Fugl Meyer Assessment</title>
        <description>Motor function subscale was assessed. Scores range from 0 to 66. Lower scores indicate greater severity.</description>
        <time_frame>6 months follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Upper Extremity Fugl Meyer Assessment</title>
          <description>Motor function subscale was assessed. Scores range from 0 to 66. Lower scores indicate greater severity.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42" spread="13"/>
                    <measurement group_id="O2" value="34" spread="14.9"/>
                    <measurement group_id="O3" value="44.5" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Adverse Events</title>
        <time_frame>6 months follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adverse Events</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>headache</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>pain on shoulder mobilization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>dizziness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>syncope</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>seizures</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>dysesthesia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>psychiatric disorder</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>sleep</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Fatigue Severity Scale</title>
        <description>Fatigue Severity Scale is a 9 -item questionnaire. Each item scores on a 7-point scale.&#xD;
The total score range from 9 to 63 points. Higher scores indicate greater fatigue.</description>
        <time_frame>6 weeks from baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fatigue Severity Scale</title>
          <description>Fatigue Severity Scale is a 9 -item questionnaire. Each item scores on a 7-point scale.&#xD;
The total score range from 9 to 63 points. Higher scores indicate greater fatigue.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="11.4"/>
                    <measurement group_id="O2" value="-1.7" spread="16.3"/>
                    <measurement group_id="O3" value="-30.7" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Pittsburgh Sleep Quality Index</title>
        <description>The global Pittsburgh Sleep Quality Index score is calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21. Lower scores denote a healthier sleep quality.</description>
        <time_frame>6 weeks from baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
          </group>
          <group group_id="O3">
            <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
            <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pittsburgh Sleep Quality Index</title>
          <description>The global Pittsburgh Sleep Quality Index score is calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21. Lower scores denote a healthier sleep quality.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="1.0"/>
                    <measurement group_id="O2" value="-2.3" spread="2.5"/>
                    <measurement group_id="O3" value="0.3" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>06 months</time_frame>
      <desc>Data about adverse effect were collected in each session of treatment, for each different intervention - tDCS, Physical Therapy, and motor therapy (Robotic therapy or Occupational Therapy).&#xD;
All minor adverse events related (tingling, pinching, fatigue, pain, sleepiness, fatigue and pain) were considered treatment-related and reported to Ethical Committee. Two events of fall outside the hospital were related and considered non-treatment-related.</desc>
      <group_list>
        <group group_id="E1">
          <title>Active tDCS + Robotic Therapy + Physical Therapy</title>
          <description>Active tDCS (transcranial direct current stimulation) will be applied prior to the robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Active tDCS: Active tDCS will be applied with the cathode positioned over the ipsilesional primary motor cortex and the anode over the contralateral supraorbital region for 20 minutes (1mA).&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
        </group>
        <group group_id="E2">
          <title>Sham tDCS + Robotic Therapy + Physical Therapy</title>
          <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to robotic training. After robot training, the patient will receive physical therapy for 40 minutes.&#xD;
Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Robotic Therapy: Robotic therapy (MIT - Manus, Interactive Motion Technologies) will be administered for 40 minutes to the paretic upper limb.&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.</description>
        </group>
        <group group_id="E3">
          <title>Sham tDCS + Physical Therapy + Occupational Therapy</title>
          <description>Sham tDCS (transcranial direct current stimulation) will be applied prior to conventional therapy (40 minutes of physical therapy and 40 minutes of occupational therapy) Number of treatment sessions: 18 (3 times a week, for 6 weeks).&#xD;
Sham tDCS: In sham tDCS, no current will be delivered through the tDCS device.&#xD;
Physical Therapy: Physical therapy will be administered for 40 minutes.&#xD;
Occupational Therapy: Occupational therapy will be administered for 40 minutes.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <description>Tolerability to motor interventions (Robotic Therapy or Occupational Therapy)</description>
                <counts group_id="E1" events="10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="7" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E3" events="8" subjects_affected="1" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <description>Tolerability to motor interventions (Robotic Therapy or Occupational Therapy)</description>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="11" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E3" events="4" subjects_affected="2" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <description>Tolerability to Physical Therapy interventions</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="8" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <description>Tolerability to Physical Therapy interventions</description>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E2" events="11" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E3" events="13" subjects_affected="1" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Sleepiness</sub_title>
                <description>Tolerability to motor interventions (Robotic Therapy or Occupational Therapy)</description>
                <counts group_id="E1" events="5" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Tingling</sub_title>
                <description>Tolerability to tDCS intervention</description>
                <counts group_id="E1" events="53" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E2" events="13" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E3" events="20" subjects_affected="2" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Pinching</sub_title>
                <description>Tolerability to tDCS intervention</description>
                <counts group_id="E1" events="5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" events="15" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E3" events="16" subjects_affected="2" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study was stopped earlier due to low recruitment rates. We consider psychosocial aspects and poor family support as an important factor to these low rates. The small sample size (9 patients) does not allow conclusions with statistical relevance.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Professor Adriana Bastos Conforto</name_or_title>
      <organization>Neurostimulation Laboratory, Hospital das Clínicas/São Paulo University, Brazil</organization>
      <phone>+55 11 2661-7955</phone>
      <email>adriana.conforto@hc.fm.usp.br</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

